Grzegorz Goñda
Plus aucun poste en cours
Profil
Mr. Grzegorz Goñda is on the Board of Directors at ERNE VENTURES SA.
Mr. Goñda was previously employed as an Analyst by KBC Securities NV.
Anciens postes connus de Grzegorz Goñda
| Sociétés | Poste | Fin |
|---|---|---|
| KBC Securities NV (Poland) | Analyst-Equity | 01/02/2005 |
| ERNE VENTURES SA | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Erne Ventures SA
 Erne Ventures SA Specialty StoresRetail Trade Erne Ventures SA is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; RX-5902 or Supinoxin for metastatic triple negative breast cancer; and RX-0201 or Archexin for renal cell carcinoma, glioblastoma, ovarian, stomach, and pancreatic cancer. It also develops nano-based drug delivery systems. The company was founded by Arkadiusz Stefan Kuich in September 2007 and is headquartered in Warszawa, Poland. | Retail Trade |
| KBC Securities NV (Poland) | Finance |
